Pazotab 200mg Tablet
Marketer
Adley Formulations
Salt Composition
Pazopanib (200mg)
Overview Pazotab 200mg Tablet
Pax kinase inhibitor, available as a 200mg tablet, combats kidney cancer and soft tissue sarcoma. Administer this medication on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician, dependent on your specific condition and subject to adjustment. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdosage may lead to severe adverse reactions. Therapeutic effects might not be apparent for several weeks or months; discontinue only under your physician's guidance. Common side effects include elevated blood pressure and diarrhea. Regular blood pressure monitoring may be recommended. Manage diarrhea by increasing fluid intake; consult your doctor if it persists. This medication can lower blood cell counts, increasing infection risk. Report fever, flu-like symptoms, or breathlessness immediately. Prior to initiating treatment, disclose any pre-existing heart, liver, or kidney conditions, or the use of any anti-infective medications. Inform your healthcare provider of all concurrent medications as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment.
Primary Ingredients of Pazotab 200mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Pazotab 200mg Tablet
Renal cell carcinoma or soft tissue sarcoma
Major Benefits of Pazotab 200mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Pazotab 200mg Tablet on an empty stomach.
Common Side effects of Pazotab 200mg Tablet:
- Headache
- Nausea
- Vomiting
- Musculoskeletal (bone, muscle or joint) pain
- Fatigue
- Change in color of hair
- Diarrhea
- High blood pressure
- Decreased appetite
- Weight loss
- Taste change
- Abnormal skin pigmentation
- Hair discoloration
- Tumor pain
- Breathlessness
How to use Pazotab 200mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 200mg Pazotab tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Pazotab 200mg Tablet works:
The anti-cancer drug, Pazotab 200mg Tablet, functions by targeting and blocking tyrosine kinase enzyme receptors, crucial for cancerous cell multiplication. Its mechanism also includes the suppression of tumor angiogenesis, thereby curtailing the development of new blood vessels that feed the tumor's growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Pazotab 200mg Tablet with alcohol is undefined regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Pazotab 200mg tablets during pregnancy carries a confirmed risk to the fetus. Therefore, its use is generally inadvisable. Nevertheless, a physician might, in exceptional life-threatening circumstances, deem the potential benefits to outweigh the risks. Always seek medical advice.
Breast feedingUNSAFE
Nursing mothers should avoid Pazotab 200mg Tablets. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving should be avoided if using Pazotab 200mg Tablets, as drowsiness, blurred vision, dizziness, and reduced attentiveness may result.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Pazotab 200mg tablets without requiring any dosage modification.
LiverCAUTION
Patients with liver impairment should use 200mg Pazotab tablets cautiously, potentially requiring dose modification. A physician's consultation is recommended. Pazotab 200mg tablets are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Pazotab 200mg Tablet :
NA
Facts to Know About Pazotab 200mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Diarylalkylamines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently